BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Ca

Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic financing, and review...

Related Keywords

Qatar , United States , Philadelphia , Pennsylvania , White House , District Of Columbia , America , Matt Wiley , Vince Oneill , Canaccord Genuity , Vimal Mehta , Frank Yocca , Sumant Kulkarni , Greg Harrison , Rob Risinger , Ram Selvaraju , Richard Steinhart , Qatar Investment Authority , White House Office Of National Drug Control , Columbia University , Nasdaq , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Call Transcript November , Xcel Therapeutics , Bioxcel Therapeutics Conference Call , Chief Executive Officer , Chief Financial , Chief Commercial Officer , Chief Medical Officer , Vinceo Neill , Chief Rd Officer , Onkosxcel Therapeutics , Chief Scientific , Oaktree Capital Management , Qatar Investment , Oaktree Capital , White House Office , National Drug Control , Hedge Funds , Their Top Stock Picks , With The Largest Foreign Reserves ,